TA-GVHD

TA-GVHD

Transfusion-associated-graft-versus-host disease, see there.
References in periodicals archive ?
While TA-GVHD is a rare disorder, prevention is critical because it is a condition with greater than 80 percent mortality and no effective treatment options.
No reports of TA-GVHD events related to transfusions have been reported where hematology/oncology patients at risk for TA-GVHD were supported with INTERCEPT-treated platelets without gamma irradiation.
There is currently no available treatment for TA-GVHD and gamma irradiation has been the mainstay for prevention.